EP2373791 - COMPOSITIONS COMPRISING PROTEASE, AMYLASE AND LIPASE FOR USE IN THE TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIONS [Right-click to bookmark this link] | |||
Former [2011/41] | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND FOR THE ERADICATION OR REDUCTION OF STAPHYLOCOCCUS AUREUS ON SURFACES | ||
[2015/35] | Status | No opposition filed within time limit Status updated on 03.02.2017 Database last updated on 03.06.2024 | Most recent event Tooltip | 15.11.2019 | Lapse of the patent in a contracting state New state(s): MK | published on 18.12.2019 [2019/51] | Applicant(s) | For all designated states Curelon LLC 411 Theodore Fremd Avenue, Suite 206s Rye, NY 10580 / US | [2016/13] |
Former [2012/08] | For all designated states Curelon LLC 411 Theodore Fremd Avenue, Suite 206 South Rye, NY 10580 / US | ||
Former [2011/41] | For all designated states Curemark, LLC 411 Theodore Fremd Ave. Suite 206 Rye, NY 10580 / US | Inventor(s) | 01 /
FALLON, Joan M. 1180 Midland Avenue Bronxville New York 10708 / US | 02 /
HEIL, Matthew 47 Timber Lake Road Sherman Connecticut 06784 / US | 03 /
FALLON, James J. 11 Wampus Close Armonk New York 10504 / US | [2011/41] | Representative(s) | Patent Boutique LLP 10A Printing House Yard Hackney Road London E2 7PR / GB | [N/P] |
Former [2016/13] | Patent Boutique LLP 37 Vanbrugh Park London SE3 7AA / GB | ||
Former [2013/03] | Blance, Stephen John, et al Avidity IP Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB | ||
Former [2012/27] | Mannion, Sally Kim, et al Avidity IP Ltd Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB | ||
Former [2011/41] | Lasterra Sánchez, Elena HLBBshaw Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB | Application number, filing date | 10729462.1 | 06.01.2010 | [2016/13] | WO2010US20253 | Priority number, date | US20090142714P | 06.01.2009 Original published format: US 142714 P | US20090153274P | 17.02.2009 Original published format: US 153274 P | US20090170915P | 20.04.2009 Original published format: US 170915 P | [2011/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010080830 | Date: | 15.07.2010 | Language: | EN | [2010/28] | Type: | A1 Application with search report | No.: | EP2373791 | Date: | 12.10.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.07.2010 takes the place of the publication of the European patent application. | [2011/41] | Type: | B1 Patent specification | No.: | EP2373791 | Date: | 30.03.2016 | Language: | EN | [2016/13] | Search report(s) | International search report - published on: | US | 15.07.2010 | (Supplementary) European search report - dispatched on: | EP | 23.04.2012 | Classification | IPC: | C12N11/18, A61K38/46, A01N65/00, A01N63/02, A61P31/00, A61P31/04, A61L2/16 | [2012/21] | CPC: |
A61K38/54 (EP,US);
A61K38/43 (KR);
A01N63/10 (GB);
A01N63/50 (EP,US);
A01N65/00 (EP,GB,US);
A61K35/12 (KR);
A61K38/00 (KR);
A61K38/17 (KR);
A61K38/46 (GB);
A61K38/465 (EP,US);
A61K38/47 (EP,US);
A61K38/4826 (EP,US);
A61K45/06 (EP,US);
A61L2/0088 (EP,US);
A61L2/18 (EP,US);
A61L2/22 (EP,US);
A61P17/00 (EP);
A61P17/02 (EP);
A61P31/00 (EP);
A61P31/02 (EP);
A61P31/04 (EP);
A61P43/00 (EP);
C11D3/386 (US);
C11D3/38627 (US);
C11D3/38636 (US);
C12N11/18 (GB,KR);
C12Y301/01 (EP,US);
| C-Set: |
A01N63/50, A01N63/50 (US,EP);
A61K38/465, A61K2300/00 (US,EP);
A61K38/47, A61K2300/00 (US,EP);
A61K38/4826, A61K2300/00 (EP,US) |
Former IPC [2011/41] | C12N11/18 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2016/13] | Extension states | AL | Not yet paid | BA | Not yet paid | RS | Not yet paid | Title | German: | ZUSAMMENSETZUNGEN ENHALTEND PROTEASE, AMYLASE AND LIPASE ZUR VERWENDUNG IN DER BEHANDLUNG VON STAPHYLOCOCCUS AUREUS-INFEKTIONEN | [2015/35] | English: | COMPOSITIONS COMPRISING PROTEASE, AMYLASE AND LIPASE FOR USE IN THE TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIONS | [2015/35] | French: | COMPOSITIONS COMPRENANT LA PROTÉASE, L'AMYLASE ET LA LIPASE POUR L'UTILISATION DANS LE TRAITEMENT DES INFECTIONS PAR STAPHYLOCOCCUS AUREUS | [2015/35] |
Former [2011/41] | ZUSAMMENSETZUNGEN UND VERFAHREN FÜR DIE BEHANDLUNG BZW. PRÄVENTION VON STAPHYLOCOCCUS AUREUS-INFEKTIONEN UND DIE AUSROTTUNG BZW. DEZIMIERUNG VON STAPHYLOCOCCUS-AUREUS AUF OBERFLÄCHEN | ||
Former [2011/41] | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND FOR THE ERADICATION OR REDUCTION OF STAPHYLOCOCCUS AUREUS ON SURFACES | ||
Former [2011/41] | COMPOSITIONS ET PROCÉDÉS POUR LE TRAITEMENT OU LA PRÉVENTION D'INFECTIONS PAR STAPHYLOCOCCUS AUREUS ET POUR L'ÉRADICATION OU LA RÉDUCTION DE STAPHYLOCOCCUS AUREUS SUR DES SURFACES | Entry into regional phase | 06.07.2011 | National basic fee paid | 06.07.2011 | Search fee paid | 06.07.2011 | Designation fee(s) paid | 06.07.2011 | Examination fee paid | Examination procedure | 06.07.2011 | Examination requested [2011/41] | 26.01.2012 | Amendment by applicant (claims and/or description) | 07.01.2013 | Despatch of a communication from the examining division (Time limit: M04) | 15.05.2013 | Reply to a communication from the examining division | 08.07.2014 | Despatch of a communication from the examining division (Time limit: M04) | 18.11.2014 | Reply to a communication from the examining division | 04.03.2015 | Despatch of a communication from the examining division (Time limit: M04) | 14.07.2015 | Reply to a communication from the examining division | 06.08.2015 | Communication of intention to grant the patent | 16.12.2015 | Fee for grant paid | 16.12.2015 | Fee for publishing/printing paid | 29.01.2016 | Information about intention to grant a patent | 29.01.2016 | Receipt of the translation of the claim(s) | Divisional application(s) | EP15200616.9 / EP3064217 | EP18160053.7 / EP3351264 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.01.2013 | Opposition(s) | 03.01.2017 | No opposition filed within time limit [2017/10] | Fees paid | Renewal fee | 25.01.2012 | Renewal fee patent year 03 | 25.01.2013 | Renewal fee patent year 04 | 21.01.2014 | Renewal fee patent year 05 | 13.01.2015 | Renewal fee patent year 06 | 27.01.2016 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 06.01.2010 | AT | 30.03.2016 | BE | 30.03.2016 | BG | 30.03.2016 | CY | 30.03.2016 | CZ | 30.03.2016 | DK | 30.03.2016 | EE | 30.03.2016 | FI | 30.03.2016 | HR | 30.03.2016 | LT | 30.03.2016 | LV | 30.03.2016 | MC | 30.03.2016 | MK | 30.03.2016 | NL | 30.03.2016 | PL | 30.03.2016 | RO | 30.03.2016 | SE | 30.03.2016 | SI | 30.03.2016 | SK | 30.03.2016 | SM | 30.03.2016 | NO | 30.06.2016 | GR | 01.07.2016 | IS | 30.07.2016 | PT | 01.08.2016 | [2019/51] |
Former [2019/46] | HU | 06.01.2010 | |
AT | 30.03.2016 | ||
BE | 30.03.2016 | ||
BG | 30.03.2016 | ||
CY | 30.03.2016 | ||
CZ | 30.03.2016 | ||
DK | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
MC | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SI | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
PT | 01.08.2016 | ||
Former [2019/39] | HU | 06.01.2010 | |
AT | 30.03.2016 | ||
BE | 30.03.2016 | ||
BG | 30.03.2016 | ||
CZ | 30.03.2016 | ||
DK | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
MC | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SI | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
PT | 01.08.2016 | ||
Former [2019/31] | HU | 06.01.2010 | |
AT | 30.03.2016 | ||
BE | 30.03.2016 | ||
CZ | 30.03.2016 | ||
DK | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
MC | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SI | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
PT | 01.08.2016 | ||
Former [2017/47] | AT | 30.03.2016 | |
BE | 30.03.2016 | ||
CZ | 30.03.2016 | ||
DK | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
MC | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SI | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
PT | 01.08.2016 | ||
Former [2017/37] | AT | 30.03.2016 | |
BE | 30.03.2016 | ||
CZ | 30.03.2016 | ||
DK | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SI | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
PT | 01.08.2016 | ||
Former [2017/07] | AT | 30.03.2016 | |
BE | 30.03.2016 | ||
CZ | 30.03.2016 | ||
DK | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
PT | 01.08.2016 | ||
Former [2017/03] | AT | 30.03.2016 | |
BE | 30.03.2016 | ||
CZ | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
PT | 01.08.2016 | ||
Former [2016/51] | AT | 30.03.2016 | |
CZ | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
PT | 01.08.2016 | ||
Former [2016/50] | AT | 30.03.2016 | |
CZ | 30.03.2016 | ||
EE | 30.03.2016 | ||
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
RO | 30.03.2016 | ||
SE | 30.03.2016 | ||
SK | 30.03.2016 | ||
SM | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
Former [2016/49] | EE | 30.03.2016 | |
FI | 30.03.2016 | ||
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
NL | 30.03.2016 | ||
PL | 30.03.2016 | ||
SE | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
Former [2016/48] | FI | 30.03.2016 | |
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
NL | 30.03.2016 | ||
SE | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
IS | 30.07.2016 | ||
Former [2016/44] | FI | 30.03.2016 | |
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
NL | 30.03.2016 | ||
SE | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
Former [2016/39] | FI | 30.03.2016 | |
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
LV | 30.03.2016 | ||
SE | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
Former [2016/36] | FI | 30.03.2016 | |
HR | 30.03.2016 | ||
LT | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | ||
Former [2016/35] | FI | 30.03.2016 | |
HR | 30.03.2016 | ||
NO | 30.06.2016 | ||
GR | 01.07.2016 | Documents cited: | Search | [XY] - DAJCS JJ ET AL, "Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit", CURR EYE RES, (200106), vol. 22, no. 6, pages 451 - 457, XP009158278 [X] 1,4,6-8,15,17 * abstract * * page 451, column 1 * * page 452, column 6 * * page 453, column 3 * * page 454, column 3 * [Y] 1-17 DOI: http://dx.doi.org/10.1076/ceyr.22.6.451.5486 | [XY] - KOKAI-KUN J F ET AL, "Lysostaphin as a treatment for systemic Staphylococcus aureu sinfection in a mouse model", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (2007), vol. 60, pages 1051 - 1059, XP009158291 [X] 1,4,6,8,15,17 * page 1051, columns 1,3 * * page 1052, columns 1-5 * * page 1053 * * page 1054, column 2 * * page 1057, column 2 * [Y] 1-17 DOI: http://dx.doi.org/10.1093/jac/dkm347 | International search | [Y]US3002883 (BUTT FREDERICK J, et al); | [Y]US3357894 (JOSE URIEL, et al); | [X]US3940478 (KURTZ LEONARD D); | [Y]US6309669 (SETTERSTROM JEAN A [US], et al); | [X]US2004209790 (SAVA ALEX [AU], et al); | [Y]US2008166334 (FALLON JOAN M [US]) | Examination | EP2258837 |